Latest Neuro Event Labs News & Updates

Neuro Event Labs receives CMS NTAP approval for its seizure monitoring system

The U.S. Centers for Medicare & Medicaid Services approved additional payments of up to $975 per eligible patient case starting in October 2026.

Neuro Event Labs launches Nelli project

It receives excellent responses for its interface and videos. Nelli aids clinicians' decision-making as seizure diaries lack accuracy.

Neuro Event Labs partners with Newcastle Royal Victoria Infirmary

The hospital becomes Nelli's Centre of Excellence for NIHR-funded at-home AI monitoring of epilepsy patients with intellectual disabilities. This supports NHS transition to community care.

Neuro Event Labs attends AES meeting

Martijn W. and Reinhard Krickl seek meetings with CROs, pharma/biotech firms, hospitals, and partners. They highlight recent FDA 510(k) clearance for Nelli Seizure Monitoring System.

Artificial intelligence is revolutionizing epilepsy diagnostics - Neuro Event Labs has opened a share offering - Sijoittaja.fi

The Finnish MedTech company Neuro Event Labs is moving into the commercial growth phase. The company has opened a share offering to support its international growth.

Neuro Event Labs receives FDA clearance for Nelli Seizure Monitoring System

Neuro Event Labs has received FDA clearance for clinical use of its Nelli Seizure Monitoring System in the hospital setting.

Catalyze Capital invests in Neuro Event Labs - Catalyze

Improving nocturnal event monitoring in people with intellectual disability in community using an artificial intelligence camera - Europe PMC